Design and application of antimicrobial peptide conjugates

International Journal of Molecular Sciences

Volumn 17, Issue 5, 2016, Pages

  Reinhardt, Andre ^a   Neundorf, Ines ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Antibiotics; Antimicrobial peptide conjugates; Antimicrobial peptides; Nanoparticles; Organometallic complexes; Photosensitizer

Indexed keywords

ANTINEOPLASTIC AGENT; BACTENECIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CECROPIN; CYCLODEXTRIN; DEFENSIN; GOLD NANOPARTICLE; HISTATIN; IMMUNOGLOBULIN G; INDOLICIDIN; LIPOPEPTIDE; LIPOPOLYSACCHARIDE; MAGAININ 1; MAGAININ 2; MELITTIN; NANOMATERIAL; ORGANOMETALLIC COMPOUND; PHOTOSENSITIZING AGENT; PLASMID DNA; POLYPEPTIDE ANTIBIOTIC AGENT; PORPHYRIN; PROTEGRIN; REACTIVE OXYGEN METABOLITE; SPERMIDINE; TACHYPLESIN; ANTIMICROBIAL CATIONIC PEPTIDE; NANOPARTICLE;

ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL THERAPY; BIOFILM; CELL PERMEABILIZATION; CONJUGATE; DRUG DESIGN; DRUG MECHANISM; ENDOSOME; HEMOLYSIS; HUMAN; LIPOPHILICITY; MEMBRANE DAMAGE; METHICILLIN-RESISTANT STAPHYLOCOCCUS EPIDERMIDIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PEPTIDE SYNTHESIS; PHOTODYNAMIC THERAPY; PROTEIN CROSS LINKING; PROTEIN STRUCTURE; REVIEW; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; TRANSMISSION ELECTRON MICROSCOPY; VANCOMYCIN RESISTANT ENTEROCOCCUS; ANIMAL; CHEMISTRY;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; HUMANS; NANOPARTICLES; ORGANOMETALLIC COMPOUNDS; PHOTOSENSITIZING AGENTS;

EID: 85011843832     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17050701     Document Type: Review

References (132)

1. Marr, A.K.; Gooderham, W.J.; Hancock, R.E.W. Antibacterial peptides for therapeutic use: Obstacles and realistic outlook. Curr. Opin. Pharmacol. 2006, 6, 468-472.
2. Mygind, P.H.; Fischer, R.L.; Schnorr, K.M.; Hansen, M.T.; Sonksen, C.P.; Ludvigsen, S.; Raventos, D.; Buskov, S.; Christensen, B.; de Maria, L.; et al. Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus. Nature 2005, 437, 975-980.
3. Hof, W.V.T.; Veerman, E.C.I.; Helmerhorst, E.J.; Amerongen, A.V.N. Antimicrobial peptides: Properties and applicability. Biol. Chem. 2001, 382, 597-619.
4. Zasloff, M. Antimicrobial peptides of multicellular organisms. Nature 2002, 415, 389-395.
5. Hancock, R.E.W.; Sahl, H.G. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 2006, 24, 1551-1557.
6. Nguyen, L.T.; Haney, E.F.; Vogel, H.J. The expanding scope of antimicrobial peptide structures and their modes of action. Trends Biotechnol. 2011, 29, 464-472.
7. Fjell, C.D.; Hiss, J.A.; Hancock, R.E.W.; Schneider, G. Designing antimicrobial peptides: Form follows function. Nat. Rev. Drug Discov. 2012, 11, 37-51.
8. Hancock, R.E.W.; Lehrer, R. Cationic peptides: A new source of antibiotics. Trends Biotechnol. 1998, 16, 82-88.
9. Brogden, K.A.; Ackermann, M.; McCray, P.B.; Tack, B.F. Antimicrobial peptides in animals and their role in host defences. Int. J. Antimicrob. Agents 2003, 22, 465-478.
10. Maria-Neto, S.; de Almeida, K.C.; Macedo, M.L.R.; Franco, O.L. Understanding bacterial resistance to antimicrobial peptides: From the surface to deep inside. Biochim. Biophys. Acta Biomembr. 2015, 1848, 3078-3088.
11. Ghosh, C.; Haldar, J. Membrane-active small molecules: Designs inspired by antimicrobial peptides. Chemmedchem 2015, 10, 1606-1624.
12. Andersson, M.; Boman, A.; Boman, H.G. Ascaris nematodes from pig and human make three antibacterial peptides: Isolation of cecropin p1 and two asabf peptides. Cell. Mol. Life Sci. 2003, 60, 599-606.
13. Agerberth, B.; Gunne, H.; Odeberg, J.; Kogner, P.; Boman, H.G.; Gudmundsson, G.H. Fall-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone-marrow and testis. Proc. Natl. Acad. Sci. USA 1995, 92, 195-199.
14. Falla, T.J.; Karunaratne, D.N.; Hancock, R.E.W. Mode of action of the antimicrobial peptide indolicidin. J. Biol. Chem. 1996, 271, 19298-19303.
15. Frank, R.W.; Gennaro, R.; Schneider, K.; Przybylski, M.; Romeo, D. Amino-acid-sequences of 2 proline-rich bactenecins—Antimicrobial peptides of bovine neutrophils. J. Biol. Chem. 1990, 265, 18871-18874.
16. Wu, M.H.; Hancock, R.E.W. Interaction of the cyclic antimicrobial cationic peptide bactenecin with the outer and cytoplasmic membrane. J. Biol. Chem. 1999, 274, 29-35.
17. Dings, R.P.M.; Haseman, J.R.; Leslie, D.B.; Luong, M.; Dunn, D.L.; Mayo, K.H. Bacterial membrane disrupting dodecapeptide SC4 improves survival of mice challenged with Pseudomonas aeruginosa. BBA-Gen. Subj. 2013, 1830, 3454-3457.
18. Xu, F.; Meng, K.; Wang, Y.R.; Lu, H.Y.; Yang, P.L.; Wu, N.F.; Fan, Y.L.; Yao, B. Eukaryotic expression and antimicrobial spectrum determination of the peptide tachyplesin II. Protein Expr. Purif. 2008, 58, 175-183.
19. Findlay, B.; Zhanel, G.G.; Schweizer, F. Cationic amphiphiles, a new generation of antimicrobials inspired by the natural antimicrobial peptide scaffold. Antimicrob. Agents Chemother. 2010, 54, 4049-4058.
20. Strom, M.B.; Haug, B.E.; Skar, M.L.; Stensen, W.; Stiberg, T.; Svendsen, J.S. The pharmacophore of short cationic antibacterial peptides. J. Med. Chem. 2003, 46, 1567-1570.
21. Thaker, H.D.; Sgolastra, F.; Clements, D.; Scott, R.W.; Tew, G.N. Synthetic mimics of antimicrobial peptides from triaryl scaffolds. J. Med. Chem. 2011, 54, 2241-2254.
22. Scott, M.G.; Yan, H.; Hancock, R.E.W. Biological properties of structurally related α-helical cationic antimicrobial peptides. Infect. Immun. 1999, 67, 2005-2009.
23. Scott, M.G.; Gold, M.R.; Hancock, R.E.W. Interaction of cationic peptides with lipoteichoic acid and Gram-positive bacteria. Infect. Immun. 1999, 67, 6445-6453.
24. Matsuzaki, K. Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. BBA-Biomembranes 1999, 1462, 1-10.
25. Pag, U.; Oedenkoven, M.; Papo, N.; Oren, Z.; Shai, Y.; Sahl, H.G. In vitro activity and mode of action of diastereomeric antimicrobial peptides against bacterial clinical isolates. J. Antimicrob. Chemother. 2004, 53, 230-239.
26. Wang, P.; Bang, J.K.; Kim, H.J.; Kim, J.K.; Kim, Y.; Shin, S.Y. Antimicrobial specificity and mechanism of action of disulfide-removed linear analogs of the plant-derived Cys-rich antimicrobial peptide Ib-AMP1. Peptides 2009, 30, 2144-2149.
27. Huang, J.F.; Xu, Y.M.; Hao, D.M.; Huang, Y.B.; Liu, Y.; Chen, Y.X. Structure-guided de novo design of α-helical antimicrobial peptide with enhanced specificity. Pure Appl. Chem. 2010, 82, 243-257.
28. Huang, Y.B.; He, L.Y.; Li, G.R.; Zhai, N.C.; Jiang, H.Y.; Chen, Y.X. Role of helicity of α-helical antimicrobial peptides to improve specificity. Protein Cell 2014, 5, 631-642.
29. Oren, Z.; Shai, Y. Selective lysis of bacteria but not mammalian cells by diastereomers of melittin: Structure-function study. Biochemistry 1997, 36, 1826-1835.
30. Zhu, W.L.; Nan, Y.H.; Hahm, K.S.; Shin, S.Y. Cell selectivity of an antimicrobial peptide melittin diastereomer with D-amino acid in the leucine zipper sequence. J. Biochem. Mol. Biol. 2007, 40, 1090-1094.
31. Oren, Z.; Shai, Y. Cyclization of a non cell-selective cytolytic amphipatic α-helical peptide renders it selective to bacteria. Biophys. J. 2000, 78, 14a.
32. Song, Y.M.; Park, Y.; Lim, S.S.; Yang, S.T.; Woo, E.R.; Park, I.S.; Lee, J.S.; Kim, J.I.; Hahm, K.S.; Kim, Y.; et al. Cell selectivity and mechanism of action of antimicrobial model peptides containing peptoid residues. Biochemistry 2005, 44, 12094-12106.
33. Da Costa, J.P.; Cova, M.; Ferreira, R.; Vitorino, R. Antimicrobial peptides: An alternative for innovative medicines? Appl. Microbiol. Biotechnol. 2015, 99, 2023-2040.
34. Brogden, K.A. Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 2005, 3, 238-250.
35. Matsuzaki, K.; Murase, O.; Fujii, N.; Miyajima, K. An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation. Biochemistry 1996, 35, 11361-11368.
36. Yang, L.; Harroun, T.A.; Weiss, T.M.; Ding, L.; Huang, H.W. Barrel-stave model or toroidal model? A case study on melittin pores. Biophys. J. 2001, 81, 1475-1485.
37. Kang, S.J.; Park, S.J.; Mishig-Ochir, T.; Lee, B.J. Antimicrobial peptides: Therapeutic potentials. Expert Rev. Anti-Infect. Ther. 2014, 12, 1477-1486.
38. Di Luca, M.; Maccari, G.; Nifosi, R. Treatment of microbial biofilms in the post-antibiotic era: Prophylactic and therapeutic use of antimicrobial peptides and their design by bioinformatics tools. Pathog. Dis. 2014, 70, 257-270.
39. Ehrenstein, G.; Lecar, H. Electrically gated ionic channels in lipid bilayers. Q. Rev. Biophys. 1977, 10, 1-34.
40. Bechinger, B. The structure, dynamics and orientation of antimicrobial peptides in membranes by multidimensional solid-state nmr spectroscopy. BBA-Biomembranes 1999, 1462, 157-183.
41. Pouny, Y.; Rapaport, D.; Mor, A.; Nicolas, P.; Shai, Y. Interaction of antimicrobial dermaseptin and its fluorescently labeled analogs with phospholipid-membranes. Biochemistry 1992, 31, 12416-12423.
42. Shai, Y. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by α-helical antimicrobial and cell non-selective membrane-lytic peptides. BBA-Biomembranes 1999, 1462, 55-70.
43. Ladokhin, A.S.; White, S.H. “Detergent-like” permeabilization of anionic lipid vesicles by melittin. BBA-Biomembranes 2001, 1514, 253-260.
44. Fernandez, D.I.; Le Brun, A.P.; Whitwell, T.C.; Sani, M.A.; James, M.; Separovic, F. The antimicrobial peptide aurein 1.2 disrupts model membranes via the carpet mechanism. Phys. Chem. Chem. Phys. 2012, 14, 15739-15751.
45. Brotz, H.; Bierbaum, G.; Leopold, K.; Reynolds, P.E.; Sahl, H.G. The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid ii. Antimicrob. Agents Chemother. 1998, 42, 154-160.
46. Kavanagh, K.; Dowd, S. Histatins: Antimicrobial peptides with therapeutic potential. J. Pharm. Pharmacol. 2004, 56, 285-289.
47. Andreu, D.; Rivas, L. Animal antimicrobial peptides: An overview. Biopolymers 1998, 47, 415-433.
48. Kragol, G.; Lovas, S.; Varadi, G.; Condie, B.A.; Hoffmann, R.; Otvos, L. The antibacterial peptide pyrrhocoricin inhibits the atpase actions of dnak and prevents chaperone-assisted protein folding. Biochemistry 2001, 40, 3016-3026.
49. Lehrer, R.I.; Barton, A.; Daher, K.A.; Harwig, S.S.L.; Ganz, T.; Selsted, M.E. Interaction of human defensins with Escherichia-coli—Mechanism of bactericidal activity. J. Clin. Investig. 1989, 84, 553-561.
50. Boman, H.G.; Agerberth, B.; Boman, A. Mechanisms of action on Escherichia coli of cecropin-P1 and PR-39, 2 antibacterial peptides from pig intestine. Infect. Immun. 1993, 61, 2978-2984.
51. Subbalakshmi, C.; Sitaram, N. Mechanism of antimicrobial action of indolicidin. FEMS Microbiol. Lett. 1998, 160, 91-96.
52. Patrzykat, A.; Friedrich, C.L.; Zhang, L.J.; Mendoza, V.; Hancock, R.E.W. Sublethal concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli. Antimicrob. Agents Chemother. 2002, 46, 605-614.
53. Splith, K.; Neundorf, I. Antimicrobial peptides with cell-penetrating peptide properties and vice versa. Eur. Biophys. J. Biophys. 2011, 40, 387-397.
54. Brogden, N.K.; Brogden, K.A. Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals? Int. J. Antimicrob. Agents 2011, 38, 217-225.
55. Dosselli, R.; Gobbo, M.; Bolognini, E.; Campestrini, S.; Reddi, E. Porphyrin—Apidaecin conjugate as a new broad spectrum antibacterial agent. ACS Med. Chem. Lett. 2010, 1, 35-38.
56. Chu-Kung, A.F.; Nguyen, R.; Bozzelli, K.N.; Tirrell, M. Chain length dependence of antimicrobial peptide-fatty acid conjugate activity. J. Colloid Interface Sci. 2010, 345, 160-167.
57. Soler, M.; Gonzalez-Bartulos, M.; Soriano-Castell, D.; Ribas, X.; Costas, M.; Tebar, F.; Massaguer, A.; Feliu, L.; Planas, M. Identification of BP16 as a non-toxic cell-penetrating peptide with highly efficient drug delivery properties. Org. Biomol. Chem. 2014, 12, 1652-1663.
58. Jang, J.H.; Kim, M.Y.; Lee, J.W.; Kim, S.C.; Cho, J.H. Enhancement of the cancer targeting specificity of buforin lib by fusion with an anionic peptide via a matrix metalloproteinases-cleavable linker. Peptides 2011, 32, 895-899.
59. Rai, A.; Pinto, S.; Evangelista, M.B.; Gil, H.; Kallip, S.; Ferreira, M.G.; Ferreira, L. High-density antimicrobial peptide coating with broad activity and low cytotoxicity against human cells. Acta Biomater. 2016, 33, 64-77.
60. Rivero-Muller, A.; Vuorenoja, S.; Tuominen, M.; Waclawik, A.; Brokken, L.J.S.; Ziecik, A.J.; Huhtaniemi, I.; Rahman, N.A. Use of hecate-chorionic gonadotropin β conjugate in therapy of lutenizing hormone receptor expressing gonadal somatic cell tumors. Mol. Cell. Endocrinol. 2007, 269, 17-25.
61. Sanches, P.R.S.; Carneiro, B.M.; Batista, M.N.; Braga, A.C.S.; Lorenzon, E.N.; Rahal, P.; Cilli, E.M. A conjugate of the lytic peptide hecate and gallic acid: Structure, activity against cervical cancer, and toxicity. Amino Acids 2015, 47, 1433-1443.
62. Pal, S.; Tak, Y.K.; Han, E.; Rangasamy, S.; Song, J.M. A multifunctional composite of an antibacterial higher-valent silver metallopharmaceutical and a potent wound healing polypeptide: A combined killing and healing approach to wound care. New J. Chem. 2014, 38, 3889-3898.
63. Tati, S.; Li, R.; Puri, S.; Kumar, R.; Davidow, P.; Edgerton, M. Histatin 5-spermidine conjugates have enhanced fungicidal activity and efficacy as a topical therapeutic for oral candidiasis. Antimicrob. Agents Chemother. 2014, 58, 756-766.
64. Gao, G.; Cheng, J.T.J.; Kindrachuk, J.; Hancock, R.E.W.; Straus, S.K.; Kizhakkedathu, J.N. Biomembrane interactions reveal the mechanism of action of surface-immobilized host defense IDR-1010 peptide. Chem. Biol. 2012, 19, 199-209.
65. Ghaffar, K.A.; Hussein, W.M.; Khalil, Z.G.; Capon, R.J.; Skwarczynski, M.; Toth, I. Levofloxacin and indolicidin for combination antimicrobial therapy. Curr. Drug Deliv. 2015, 12, 108-114.
66. 2 conjugated to the hydrophilic photosensitizer eosin Y. Bioconjug. Chem. 2013, 24, 114-123.
67. 2. PLoS ONE 2014, 9, e91220.
68. Mai, J.C.; Mi, Z.B.; Kim, S.H.; Ng, B.; Robbins, P.D. A proapoptotic peptide for the treatment of solid tumors. Cancer Res. 2001, 61, 7709-7712.
69. Watkins, C.L.; Brennan, P.; Fegan, C.; Takayama, K.; Nakase, I.; Futaki, S.; Jones, A.T. Cellular uptake, distribution and cytotoxicity of the hydrophobic cell penetrating peptide sequence pfvyli linked to the proapoptotic domain peptide pad. J. Control. Release 2009, 140, 237-244.
70. Kim, J.M.; Jang, S.; Yang, M.H.; Cho, H.; Lee, K.H. Characterization of antibacterial activity and synergistic effect of cationic antibacterial peptide-resin conjugates. Bull. Korean Chem. Soc. 2011, 32, 3928-3932.
71. Zhong, J.; Chau, Y. Synthesis, characterization, and thermodynamic study of a polyvalent lytic peptide-polymer conjugate as novel anticancer agent. Bioconjug. Chem. 2010, 21, 2055-2064.
72. Reinhardt, A.; Horn, M.; Schmauck, J.P.G.; Brohl, A.; Giernoth, R.; Oelkrug, C.; Schubert, A.; Neundorf, I. Novel imidazolium salt-peptide conjugates and their antimicrobial activity. Bioconjug. Chem. 2014, 25, 2166-2174.
73. Postleb, F.; Stefanik, D.; Seifert, H.; Giernoth, R. Bionic liquids: Imidazolium-based ionic liquids with antimicrobial activity. Z. Naturforsch B 2013, 68, 1123-1128.
74. Li, Y.X.; Afrasiabi, R.; Fathi, F.; Wang, N.; Xiang, C.L.; Love, R.; She, Z.; Kraatz, H.B. Impedance based detection of pathogenic E. coli O157:H7 using a ferrocene-antimicrobial peptide modified biosensor. Biosens. Bioelectron. 2014, 58, 193-199.
75. Blin, T.; Purohit, V.; Leprince, J.; Jouenne, T.; Glinel, K. Bactericidal microparticles decorated by an antimicrobial peptide for the easy disinfection of sensitive aqueous solutions. Biomacromolecules 2011, 12, 1259-1264.
76. Arnusch, C.J.; Pieters, R.J.; Breukink, E. Enhanced membrane pore formation through high-affinity targeted antimicrobial peptides. PLoS ONE 2012, 7, e39768.
77. Liu, S.; Yang, H.; Wan, L.; Cai, H.W.; Li, S.F.; Li, Y.P.; Cheng, J.Q.; Lu, X.F. Enhancement of cytotoxicity of antimicrobial peptide magainin II in tumor cells by bombesin-targeted delivery. Acta Pharmacol. Sin. 2011, 32, 79-88.
78. Perekalin, D.S.; Novikov, V.V.; Pavlov, A.A.; Ivanov, I.A.; Anisimova, N.Y.; Kopylov, A.N.; Volkov, D.S.; Seregina, I.F.; Bolshov, M.A.; Kudinov, A.R. Selective ruthenium labeling of the tryptophan residue in the bee venom peptide melittin. Chem. Eur. J. 2015, 21, 4923-4925.
79. Franzel, B.; Frese, C.; Penkova, M.; Metzler-Nolte, N.; Bandow, J.E.; Wolters, D.A. Corynebacterium glutamicum exhibits a membrane-related response to a small ferrocene-conjugated antimicrobial peptide. J. Biol. Inorg. Chem. 2010, 15, 1293-1303.
80. Albada, H.B.; Prochnow, P.; Bobersky, S.; Langklotz, S.; Schriek, P.; Bandow, J.E.; Metzler-Nolte, N. Tuning the activity of a short Arg-Trp antimicrobial peptide by lipidation of a C-or N-terminal lysine side-chain. ACS Med. Chem. Lett. 2012, 3, 980-984.
81. Hoyer, J.; Schatzschneider, U.; Schulz-Siegmund, M.; Neundorf, I. Dimerization of a cell-penetrating peptide leads to enhanced cellular uptake and drug delivery. Beilstein J. Org. Chem. 2012, 8, 1788-1797.
82. Franzman, M.R.; Burnell, K.K.; Dehkordi-Vakil, F.H.; Guthmiller, J.M.; Dawson, D.V.; Brogden, K.A. Targeted antimicrobial activity of a specific IgG-SMAP28 conjugate against Porphyromonas gingivalis in a mixed culture. Int. J. Antimicrob. Agents 2009, 33, 14-20.
83. Leptihn, S.; Har, J.Y.; Chen, J.Z.; Ho, B.; Wohland, T.; Ding, J.L. Single molecule resolution of the antimicrobial action of quantum dot-labeled sushi peptide on live bacteria. BMC Biol. 2009, 7, 22.
84. Ferreira, S.Z.; Carneiro, H.C.; Lara, H.A.; Alves, R.B.; Resende, J.M.; Oliveira, H.M.; Silva, L.M.; Santos, D.A.; Freitas, R.P. Synthesis of a new peptide-coumarin conjugate: A potential agent against cryptococcosis. ACS Med. Chem. Lett. 2015, 6, 271-275.
85. Welling, M.M.; Bunschoten, A.; Kuil, J.; Nelissen, R.G.H.H.; Beekman, F.J.; Buckle, T.; van Leeuwen, F.W.B. Development of a hybrid tracer for spect and optical imaging of bacterial infections. Bioconjug. Chem. 2015, 26, 839-849.
86. Chen, H.; Liu, C.; Chen, D.; Madrid, K.; Peng, S.; Dong, X.; Zhang, M.; Gu, Y. Bacteria-targeting conjugates based on antimicrobial peptide for bacteria diagnosis and therapy. Mol. Pharm. 2015, 12, 2505-2516.
87. Liu, F.; Ni, A.S.Y.; Lim, Y.; Mohanram, H.; Bhattacharjya, S.; Xing, B.G. Lipopolysaccharide neutralizing peptide-porphyrin conjugates for effective photoinactivation and intracellular imaging of Gram-negative bacteria strains. Bioconjug. Chem. 2012, 23, 1639-1647.
88. Yadav, S.; Mahato, M.; Pathak, R.; Jha, D.; Kumar, B.; Deka, S.R.; Gautam, H.K.; Sharma, A.K. Multifunctional self-assembled cationic peptide nanostructures efficiently carry plasmid DNA in vitro and exhibit antimicrobial activity with minimal toxicity. J. Mater. Chem. B 2014, 2, 4848-4861.
89. Arnusch, C.J.; Ulm, H.; Josten, M.; Shadkchan, Y.; Osherov, N.; Sahl, H.G.; Shai, Y. Ultrashort peptide bioconjugates are exclusively antifungal agents and synergize with cyclodextrin and amphotericin B. Antimicrob. Agents Chemther. 2012, 56, 1-9.
90. Bera, S.; Zhanel, G.G.; Schweizer, F. Synthesis and antibacterial activity of amphiphilic lysine-ligated neomycin B conjugates. Carbohydr. Res. 2011, 346, 560-568.
91. Magoulas, G.E.; Kostopoulou, O.N.; Garnelis, T.; Athanassopoulos, C.M.; Kournoutou, G.G.; Leotsinidis, M.; Dinos, G.P.; Papaioannou, D.; Kalpaxis, D.L. Synthesis and antimicrobial activity of chloramphenicol-polyamine conjugates. Bioorgan. Med. Chem. 2015, 23, 3163-3174.
92. Brouwer, C.P.J.M.; Bogaards, S.J.P.; Wulferink, M.; Velders, M.P.; Welling, M.M. Synthetic peptides derived from human antimicrobial peptide ubiquicidin accumulate at sites of infections and eradicate (multi-drug resistant) Staphylococcus aureus in mice. Peptides 2006, 27, 2585-2591.
93. Kumar, V.; Jones, G.S.; Blacksberg, I.; Remers, W.A.; Misiek, M.; Pursiano, T.A. Aminoglycoside antibiotics. 3. Epimino derivatives of neamine, ribostamycin, and kanamycin-B. J. Med. Chem. 1980, 23, 42-49.
94. Zhang, J.J.; Chiang, F.I.; Wu, L.; Czyryca, P.G.; Li, D.; Chang, C.W.T. Surprising alteration of antibacterial activity of 5”-modified neomycin against resistant bacteria. J. Med. Chem. 2008, 51, 7563-7573.
95. Borkow, G.; Vijayabaskar, V.; Lara, H.H.; Kalinkovich, A.; Lapidot, A. Structure-activity relationship of neomycin, paromomycin, and neamine-arginine conjugates, targeting HIV-1 gp120-CXCR4 binding step. Antivir. Res. 2003, 60, 181-192.
96. Chu-Kung, A.F.; Bozzelli, K.N.; Lockwood, N.A.; Haseman, J.R.; Mayo, K.H.; Tirrell, M.V. Promotion of peptide antimicrobial activity by fatty acid conjugation. Bioconjug. Chem. 2004, 15, 530-535.
97. Wenzel, M.; Schriek, P.; Prochnow, P.; Albada, H.B.; Metzler-Nolte, N.; Bandow, J.E. Influence of lipidation on the mode of action of a small RW-rich antimicrobial peptide. Biochim. Biophys. Acta 2015, 1858, 1004-1011.
98. Dai, T.; Huang, Y.Y.; Hamblin, M.R. Photodynamic therapy for localized infections-state of the art. Photodiagn. Photodyn. 2009, 6, 170-188.
99. Kochevar, I.E.; Redmond, R.W. Photosensitized production of singlet oxygen. Method Enzymol. 2000, 319, 20-28.
100. Maisch, T.; Hackbarth, S.; Regensburger, J.; Felgentrager, A.; Baumler, W.; Landthaler, M.; Roder, B. Photodynamic inactivation of multi-resistant bacteria (pib)—A new approach to treat superficial infections in the 21st century. J. Dtsch. Dermatol. Ges. 2011, 9, 360-366.
101. Vera, D.M.A.; Haynes, M.H.; Ball, A.R.; Dai, T.H.; Astrakas, C.; Kelso, M.J.; Hamblin, M.R.; Tegos, G.P. Strategies to potentiate antimicrobial photoinactivation by overcoming resistant phenotypes. Photochem. Photobiol. 2012, 88, 499-511.
102. Segalla, A.; Borsarelli, C.D.; Braslavsky, S.E.; Spikes, J.D.; Roncucci, G.; Dei, D.; Chiti, G.; Jori, G.; Reddi, E. Photophysical, photochemical and antibacterial photosensitizing properties of a novel octacationic Zn(II)-phthalocyanine. Photochem. Photobiol. Sci. 2002, 1, 641-648.
103. Usacheva, M.N.; Teichert, M.C.; Biel, M.A. Comparison of the methylene blue and toluidine blue photobactericidal efficacy against Gram-positive and Gram-negative microorganisms. Lasers Surg. Med. 2001, 29, 165-173.
104. Maisch, T.; Bosl, C.; Szeimies, R.M.; Lehn, N.; Abels, C. Photodynamic effects of novel XF porphyrin derivatives on prokaryotic and eukaryotic cells. Antimicrob. Agents Chemther. 2005, 49, 1542-1552.
105. Bonnett, R.; Buckley, D.G.; Burrow, T.; Galia, A.B.B.; Saville, B.; Songca, S.P. Photobactericidal materials based on porphyrins and phthalocyanines. J. Mater. Chem. 1993, 3, 323-324.
106. Dahl, T.A.; Midden, W.R.; Hartman, P.E. Comparison of killing of Gram-negative and Gram-positive bacteria by pure singlet oxygen. J. Bacteriol. 1989, 171, 2188-2194.
107. Perria, C.; Carai, M.; Falzoi, A.; Orunesu, G.; Rocca, A.; Massarelli, G.; Francaviglia, N.; Jori, G. Photodynamic therapy of malignant brain-tumors—Clinical-results of, difficulties with, questions about, and future-prospects for the neurosurgical applications. Neurosurgery 1988, 23, 557-563.
108. Yih, T.C.; Al-Fandi, M. Engineered nanoparticles as precise drug delivery systems. J. Cell. Biochem. 2006, 97, 1184-1190.
109. Gao, G.Z.; Lange, D.; Hilpert, K.; Kindrachuk, J.; Zou, Y.Q.; Cheng, J.T.J.; Kazemzadeh-Narbat, M.; Yu, K.; Wang, R.Z.; Straus, S.K.; et al. The biocompatibility and biofilm resistance of implant coatings based on hydrophilic polymer brushes conjugated with antimicrobial peptides. Biomaterials 2011, 32, 3899-3909.
110. Hilpert, K.; Elliott, M.; Jenssen, H.; Kindrachuk, J.; Fjell, C.D.; Korner, J.; Winkler, D.F.H.; Weaver, L.L.; Henklein, P.; Ulrich, A.S.; et al. Screening and characterization of surface-tethered cationic peptides for antimicrobial activity. Chem. Biol. 2009, 16, 58-69.
111. Eckert, R. Road to clinical efficacy: Challenges and novel strategies for antimicrobial peptide development. Future Microbiol. 2011, 6, 635-651.
112. Bandow, J.E.; Metzler-Nolte, N. New ways of killing the beast: Prospects for inorganic-organic hybrid nanomaterials as antibacterial agents. Chembiochem 2009, 10, 2847-2850.
113. Chantson, J.T.; Falzacappa, M.V.V.; Crovella, S.; Metzler-Nolte, N. Solid-phase synthesis, characterization, and antibacterial activities of metallocene-peptide bioconjugates. Chemmedchem 2006, 1, 1268-1274.
114. Chan, D.I.; Prenner, E.J.; Vogel, H.J. Tryptophan-and arginine-rich antimicrobial peptides: Structures and mechanisms of action. BBA-Biomembranes 2006, 1758, 1184-1202.
115. Oudhoff, M.J.; Bolscher, J.G.M.; Nazmi, K.; Kalay, H.; Hof, W.V.T.; Amerongen, A.V.N.; Veerman, E.C.I. Histatins are the major wound-closure stimulating factors in human saliva as identified in a cell culture assay. FASEB J. 2008, 22, 3805-3812.
116. Mannoor, M.S.; Zhang, S.Y.; Link, A.J.; McAlpine, M.C. Electrical detection of pathogenic bacteria via immobilized antimicrobial peptides. Proc. Natl. Acad. Sci. USA 2010, 107, 19207-19212.
117. Moreno, M.; Giralt, E. Three valuable peptides from bee and wasp venoms for therapeutic and biotechnological use: Melittin, apamin and mastoparan. Toxins 2015, 7, 1126-1150.
118. Szczepanski, C.; Tenstad, O.; Baumann, A.; Martinez, A.; Myklebust, R.; Bjerkvig, R.; Prestegarden, L. Identification of a novel lytic peptide for the treatment of solid tumours. Genes Cancer 2014, 5, 186-200.
119. Dathe, M.; Wieprecht, T.; Nikolenko, H.; Handel, L.; Maloy, W.L.; MacDonald, D.L.; Beyermann, M.; Bienert, M. Hydrophobicity, hydrophobic moment and angle subtended by charged residues modulate antibacterial and haemolytic activity of amphipathic helical peptides. FEBS Lett. 1997, 403, 208-212.
120. Javadpour, M.M.; Juban, M.M.; Lo, W.C.J.; Bishop, S.M.; Alberty, J.B.; Cowell, S.M.; Becker, C.L.; McLaughlin, M.L. De novo antimicrobial peptides with low mammalian cell toxicity. J. Med. Chem. 1996, 39, 3107-3113.
121. Alves, I.D.; Carre, M.; Montero, M.P.; Castano, S.; Lecomte, S.; Marquant, R.; Lecorche, P.; Burlina, F.; Schatz, C.; Sagan, S.; et al. A proapoptotic peptide conjugated to penetratin selectively inhibits tumor cell growth. BBA-Biomembranes 2014, 1838, 2087-2098.
122. 2 peptide in mouse B16(F10) melanoma model. Acta Biochim. Pol. 2006, 53, 801-805.
123. Mi, Z.B.; Mai, J.; Lu, X.L.; Robbins, P.D. Characterization of a class of cationic peptides able to facilitate efficient protein transduction in vitro and in vivo. Mol. Ther. 2000, 2, 339-347.
124. Larrick, J.W.; Hirata, M.; Balint, R.F.; Lee, J.; Zhong, J.; Wright, S.C. Human cap18—A novel antimicrobial lipopolysaccharide-binding protein. Infect. Immun. 1995, 63, 1291-1297.
125. Neundorf, I.; Rennert, R.; Hoyer, J. Fusion of a short HA2-derived peptide sequence to cell-penetrating peptides improves cytosolic uptake, but enhances cytotoxic activity. Pharmaceuticals 2009, 2, 49-65.
126. Foekens, J.A.; Kos, J.; Peters, H.A.; Krasovec, M.; Look, M.P.; Cimerman, N.; Meijer-van Gelder, M.E.; Henzen-Logmans, S.C.; van Putten, W.L.J.; Klijn, J.G.M. Prognostic significance of cathepsins B and L in primary human breast cancer. J. Clin. Oncol. 1998, 16, 1013-1021.
127. Splith, K.; Hu, W.N.; Schatzschneider, U.; Gust, R.; Ott, I.; Onambele, L.A.; Prokop, A.; Neundorf, I. Protease-activatable organometal-peptide bioconjugates with enhanced cytotoxicity on cancer cells. Bioconjug. Chem. 2010, 21, 1288-1296.
128. Al-Rifai, A.A.; Ayoub, M.T.; Shakya, A.K.; Abu Safieh, K.; Mubarak, M.S. Synthesis, characterization, and antimicrobial activity of some new coumarin derivatives. Med. Chem. Res. 2012, 21, 468-476.
129. Tietze, A.A.; Bordusa, F.; Giernoth, R.; Imhof, D.; Lenzer, T.; Maass, A.; Mrestani-Klaus, C.; Neundorf, I.; Oum, K.; Reith, D.; et al. On the nature of interactions between ionic liquids and small amino-acid-based biomolecules. Chemphyschem 2013, 14, 4044-4064.
130. Xhindoli, D.; Pacor, S.; Benincasa, M.; Scocchi, M.; Gennaro, R.; Tossi, A. The human cathelicidin LL-37 a pore-forming antibacterial peptide and host-cell modulator. BBA-Biomembranes 2016, 1858, 546-566.
131. Salomone, F.; Cardarelli, F.; Di Luca, M.; Boccardi, C.; Nifosi, R.; Bardi, G.; Di Bari, L.; Serresi, M.; Beltram, F. A novel chimeric cell-penetrating peptide with membrane-disruptive properties for efficient endosomal escape. J. Control. Release 2012, 163, 293-303.
132. Luan, L.; Meng, Q.B.; Xu, L.; Meng, Z.; Yan, H.S.; Liu, K.L. Peptide amphiphiles with multifunctional fragments promoting cellular uptake and endosomal escape as efficient gene vectors. J. Mater. Chem. B 2015, 3, 1068-1078.